טוען...

Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination

BACKGROUND: Thirteen-valent pneumococcal conjugate vaccine (PCV13) was introduced in Malawi in November 2011 and is offered to infants at 6, 10 and 14 weeks of age as part of routine immunisation. PCV13 is expected to reduce vaccine type (VT) nasopharyngeal carriage, leading to reduced transmission...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Vaccine
Main Authors: Heinsbroek, Ellen, Tafatatha, Terence, Phiri, Amos, Swarthout, Todd D, Alaerts, Maaike, Crampin, Amelia C, Chisambo, Christina, Mwiba, Oddie, Read, Jonathan M, French, Neil
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier Science 2018
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238076/
https://ncbi.nlm.nih.gov/pubmed/30352744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.10.021
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!